KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
News
Neutral

Vitalik's Unrequested Shiba Inu Tokens Funded Coronavirus Vaccine Trial

Published October 13, 2026 7:59 PM · 5 views $SHIB
Vitalik's Unrequested Shiba Inu Tokens Funded Coronavirus Vaccine Trial

Ethereum co-founder Vitalik Buterin has provided funding for an ongoing coronavirus vaccine trial. The development of this vaccine was supported by hundreds of millions of dollars worth of Shiba Inu (SHIB) tokens, which Buterin did not request.

Shiba Inu itself is facing challenges, with its meme coin price dropping 4.33% over the past 24 hours. However, the SHIB team claims to have shown early breakout signals.

PopVax, an India-based biotech startup headquartered in Hyderabad, conducted the first two doses of a coronavirus vaccine trial on August 31 in Melbourne, Australia. According to PopVax, Buterin's scientific fund Balvi and the Gates Foundation contributed a total of $20 million to this program.

PopVax stated that Balvi received funds from SHIB tokens sent to Buterin without his consent in May 2021. At that time, Buterin burned 90% of these tokens, which were worth over $6 billion at the time. He later donated $1 billion worth of SHIB tokens to a humanitarian fund for coronavirus relief.

PopVax founder Soham Sankaran stated that after Phase I clinical trials conclude, the vaccine will be open-sourced in collaboration with Balvi. Buterin also recommended PopVax to his followers on X (formerly Twitter).

Meanwhile, Shiba Inu is under pressure as its meme coin faces forced liquidations exacerbating price declines. The team claims this pattern occurs when excessive leverage meets correction periods. According to Bitcointalk's SHIB price page, the token has fallen 9.64% over the past seven days.

Despite this, the team asserts that the market is showing signs of a potential rebound, citing multiple early breakout signals from SHIB. This optimism emerged following a large-scale sell-off in cryptocurrency markets earlier this month, which exposed leveraged traders to risk.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 비탈릭, 요청하지 않은 시바이누 토큰…코로나 백신 임상 지원